CN Patent

CN112996527B — 用于治疗真菌感染的化合物和方法

Assigned to Basil Pharmaceuticals Allschwil International Ag · Expires 2025-02-21 · 1y expired

What this patent protects

本文提供了用于治疗真菌感染和疾病的组合物及其使用方法。

USPTO Abstract

本文提供了用于治疗真菌感染和疾病的组合物及其使用方法。

Drugs covered by this patent

Luzu (LULICONAZOLE) · Bausch Health

Patent Metadata

Patent number: CN112996527B
Jurisdiction: CN
Classification: —
Expires: 2025-02-21
Drug substance claim: No
Drug product claim: No
Assignee: Basil Pharmaceuticals Allschwil International Ag
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.